Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
life sciences
national
national blog main
national top stories
new york top stories
roche
2
×
san francisco top stories
billy dunn
biogen
biotech
blueprint medicines
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug prices
drug pricing
drugs
entrectinib
europe top stories
evrysdi
express scripts
foundation medicine
gene therapy
genentech
indiana blog main
indiana top stories
ionis pharmaceuticals
josh bilenker
keytruda
larotrectinib
loxo oncology
melanie nallicheri
What
approved
2
×
drug
fda
medicine
new
atrophy
cancer
daily
deeper
dna
evrysdi
fingerprint
friday
genetic
going
green
home
intended
lights
liquid
matter
muscular
nd
oks
oral
patients
risdiplam
roche
second
spinal
targets
therapy
time
tissues
tumor's
world
Language
unset
Current search:
roche
×
approved
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
